Methods |
Randomised controlled trial |
Participants |
Babies |
Interventions |
Ampicillin
Placebo |
Outcomes |
Length of hospital stay
Symptoms (not specified)
Switch to treatment arm
Death |
Notes |
No deaths or apparent side effects reported from the use of ampicillin |
Risk of bias |
Bias |
Authors' judgement |
Support for judgement |
Random sequence generation (selection bias) |
Low risk |
Randomised |
Allocation concealment (selection bias) |
Unclear risk |
Risk unclear |
Blinding (performance bias and detection bias)
All outcomes |
Low risk |
Patients were blinded but not doctors nor outcome assessors |
Incomplete outcome data (attrition bias)
All outcomes |
High risk |
No intention‐to‐treat analysis but withdrawal rates were acceptable |
Selective reporting (reporting bias) |
Low risk |
|
Other bias |
Unclear risk |
Funding sources do not appear to be identified. Beechams Research Laboratories supplied both the ampicillin and the placebo |